HealthcareLisata jumps on FDA orphan drug status for liver cancer drugBy Helitra.com·September 7, 2024·1 min read Lisata jumps on FDA orphan drug status for liver cancer drug Source: SeekingalphaADVERTISEMENT ADVERTISEMENTcancer drug FDA jumps Lisata liver orphan status Post navigation Previous storyAscendis raised to outperform by Oppenheimer ahead of drug launchNext storyEli Lilly bets $409M for AI-focused drug discovery
Fitness · HealthcareNew Menopause Treatment Guidelines ‘Correct’ a Treatment Concern That Left Many Women UnderservedNovember 3, 2026Menopause has been a hot topic for years, but guidance around the best and safest ways to treat symptoms has been lagging, both…
Fitness · HealthcareScientists Say These Surprising Meds May Ease Perimenopausal Brain FogNovember 3, 2026Among the more common symptoms of perimenopause—the phase prior to menopause, when hormones can fluctuate wildly—is brain fog. In fact, according to the…
Fitness · HealthcareMenopause can quietly weaken bones – here’s what research reveals about protecting themNovember 3, 2026A skeleton hanging on a door or standing in your neighbor’s yard for Halloween looks like a finished structure. But the skeleton inside…